NEW YORK, March 25 (GenomeWeb News) - Ionian Technologies has received a $2.7 million contract from the DoD's Defense Advanced Research Projects Agency to develop hand-held rapid detectors of biological agents, the company said yesterday.
Ionian, located in Upland, Calif., will develop assays and chemistry based on a DNA detection technology, Expar, that it licenses from the Keck Graduate Institute in Claremont, Calif., a subcontractor for the project.
Expar allows researchers to amplify nucleic acids isothermally and rapidly.